Active Ingredient: IBUPROFEN LYSINE
Proprietary Name: NEOPROFEN
Dosage Form; Route of Administration: INJECTABLE; INTRAVENOUS
Strength: EQ 20MG BASE/2ML (EQ 10MG BASE/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: N021903
Product Number: 001
Approval Date: Apr 13, 2006
Applicant Holder Full Name: RECORDATI RARE DISEASES INC
Marketing Status:
Prescription
Patent and Exclusivity Information